These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Tapsall JW Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600 [TBL] [Abstract][Full Text] [Related]
3. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449 [TBL] [Abstract][Full Text] [Related]
4. Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes. Limnios A; Tapsall J; Kahlmeter J; Hogan T; Ray S; Lam A; Unemo M APMIS; 2011 Jun; 119(6):356-63. PubMed ID: 21569093 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Tapsall J Expert Rev Anti Infect Ther; 2006 Aug; 4(4):619-28. PubMed ID: 17009941 [TBL] [Abstract][Full Text] [Related]
6. Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Lewis DA Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008. ; ; Tapsall JW; Limnios EA; Abu Bakar HM; Darussalam B; Ping YY; Buadromo EM; Kumar P; Singh S; Lo J; Bala M; Risbud A; Deguchi T; Tanaka M; Watanabe Y; Lee K; Chong Y; Noikaseumsy S; Phouthavane T; Sam IC; Tundev O; Lwin KM; Eh PH; Goarant C; Goursaud R; Bathgate T; Brokenshire M; Latorre L; Velemu E; Carlos C; Leano S; Telan EO; Goh SS; Koh ST; Ngan C; Tan AL; Mananwatte S; Piyanoot N; Lokpichat S; Sirivongranson P; Fakahau M; Sitanilei H; Hung le V Commun Dis Intell Q Rep; 2010 Mar; 34(1):1-7. PubMed ID: 20521493 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002. Commun Dis Intell Q Rep; 2003; 27(4):488-91. PubMed ID: 15508502 [TBL] [Abstract][Full Text] [Related]
9. Surveillance of gonococcal antimicrobial susceptibility resulting in early detection of emerging resistance. Lo JY; Ho KM; Lo AC J Antimicrob Chemother; 2012 Jun; 67(6):1422-6. PubMed ID: 22334602 [TBL] [Abstract][Full Text] [Related]
10. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. Whiley DM; Jacobsson S; Tapsall JW; Nissen MD; Sloots TP; Unemo M J Antimicrob Chemother; 2010 Dec; 65(12):2543-7. PubMed ID: 20940180 [TBL] [Abstract][Full Text] [Related]
11. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634 [TBL] [Abstract][Full Text] [Related]
12. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. World Health Organization. Commun Dis Intell Q Rep; 2002; 26(4):541-5. PubMed ID: 12549520 [TBL] [Abstract][Full Text] [Related]
13. The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance. Goire N; Freeman K; Lambert SB; Nimmo GR; Limnios AE; Lahra MM; Nissen MD; Sloots TP; Whiley DM Sex Health; 2012 Nov; 9(5):422-9. PubMed ID: 23036167 [TBL] [Abstract][Full Text] [Related]
14. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? Chisholm SA; Mouton JW; Lewis DA; Nichols T; Ison CA; Livermore DM J Antimicrob Chemother; 2010 Oct; 65(10):2141-8. PubMed ID: 20693173 [TBL] [Abstract][Full Text] [Related]
15. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Tapsall JW; Ndowa F; Lewis DA; Unemo M Expert Rev Anti Infect Ther; 2009 Sep; 7(7):821-34. PubMed ID: 19735224 [TBL] [Abstract][Full Text] [Related]
16. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines. De Jongh M; Dangor Y; Adam A; Hoosen AA Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048 [TBL] [Abstract][Full Text] [Related]
17. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Lo JY; Ho KM; Leung AO; Tiu FS; Tsang GK; Lo AC; Tapsall JW Antimicrob Agents Chemother; 2008 Oct; 52(10):3564-7. PubMed ID: 18663018 [TBL] [Abstract][Full Text] [Related]
18. Update on the management of gonorrhea in adults in the United States. Newman LM; Moran JS; Workowski KA Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672 [TBL] [Abstract][Full Text] [Related]
19. Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrhoea, 1997. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme-WHO WPR GASP. Commun Dis Intell; 1998 Dec; 22(13):288-91. PubMed ID: 9893340 [TBL] [Abstract][Full Text] [Related]
20. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Golparian D; Hellmark B; Fredlund H; Unemo M Sex Transm Infect; 2010 Nov; 86(6):454-60. PubMed ID: 20940159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]